SCHEMBL6807342

SCHEMBL6807342

Cc1cc(N)ccc1OCCN(C(C)C)C(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 9/20 0.48
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 3/20 0.41
GAA P10253 2/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
CASP1 P29466 1/20 0.41
HTT P42858 1/20 0.41
CASP7 P55210 1/20 0.41
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.41
CHRNB2 P17787 1/20 0.40
CHRNA4 P43681 1/20 0.40
LTA4H P09960 1/20 0.40
ESR1 P03372 3/20 0.39
ESR2 Q92731 2/20 0.39
HTR2C P28335 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6922538 0.88 ALDH1A1 (0.41) MCHR1KDM4EALDH1A1GAAMEN1
SCHEMBL4198415 0.83 GAA (0.55) MCHR1KDM4EALDH1A1GAAMAPT
SCHEMBL6204180 0.83 GAA (0.47) MCHR1KDM4EALDH1A1GAAMEN1
SCHEMBL188764 0.82 KDM4E (0.64) KDM4EALDH1A1GAAMEN1USP2
SCHEMBL20496732 0.81 ALDH1A1 (0.53) KDM4EALDH1A1GAAMEN1USP2
Hydrochloric Acid SCHEMBL2255351 0.81 KDM4E (0.62) KDM4EALDH1A1GAAMEN1USP2
SCHEMBL6927859 0.80 GAA (0.41) MCHR1KDM4EALDH1A1GAAMEN1
SCHEMBL30694100 0.79 KDM4E (0.52) KDM4EALDH1A1GAAMEN1USP2
SCHEMBL3857789 0.79 BIRC5 (0.51) KDM4EALDH1A1GAAMEN1USP2
Hydrochloric Acid SCHEMBL6926164 0.78 GAA (0.42) MCHR1KDM4EALDH1A1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063686-A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor JOHNSON CHRISTOPHER NORBERT (GB) 2004-04-01 US disclosed
EP-1305304-A1 CARBOXAMIDE COMPOUNDS AND THEIR USE AS ANTAGONISTS OF A HUMAN 11CBY RECEPTOR SMITHKLINE BEECHAM PLC (GB) 2003-05-02 EP disclosed
WO-2002010146-A1 CARBOXAMIDE COMPOUNDS AND THEIR USE AS ANTAGONISTS OF A HUMAN 11CBY RECEPTOR SMITHKLINE BEECHAM P.L.C. (GB) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063686-A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor CNR1, GPR3, CCKAR MCHR1 133/4885KDM4E 2413/4885ALDH1A1 1692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.